Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.01 +0.01 (+0.05%)

Streaming Delayed Price Updated: 1:30 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an...

Via MarketMinute

Why Anthropic’s IPO Might Just Be Juicier Than OpenAI’s ↗

December 03, 2025

Both AI giants might launch their public market offerings next year.

Via Stocktwits

Topics Artificial Intelligence Initial Public Offering

A Tale Told Through a Bird’s Eyes: Jessica Mann’s Uplift Reimagines How We See the Natural World

December 02, 2025

Via AB Newswire

Topics Bonds

Most active S&P500 stocks in Tuesday's session ↗

December 02, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

Via Investor Brand Network

Topics Government

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.

Via Investor's Business Daily

2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗

December 02, 2025

These healthcare leaders can make you money while you sleep.

Via The Motley Fool

Topics Artificial Intelligence Cannabis Intellectual Property

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗

December 01, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗

December 01, 2025

Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.

Via Investor's Business Daily

Topics Death

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

December 01, 2025

From Pfizer Inc.

Via Business Wire

S&P 500 Kicks Off December in the Red as Markets Rediscover Gravity: A Deep Dive into the Economic Headwinds

December 01, 2025

New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging...

Via MarketMinute

Topics Artificial Intelligence Bonds ETFs

BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala

December 01, 2025

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a...

Via Newsfile

Topics Artificial Intelligence

1 Oversold Stock Primed to Rebound and 2 We Find Risky

December 01, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Topics Supply Chain

1 Profitable Stock on Our Buy List and 2 We Turn Down

December 01, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever ↗

November 30, 2025

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.

Via The Motley Fool

Topics Intellectual Property

This 7% Yielder Could Be a Top AI Play ↗

November 30, 2025

One drug developer could be on the cusp of AI-powered glory.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio ↗

November 30, 2025

If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.

Via The Motley Fool

These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗

November 30, 2025

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

Via The Motley Fool

Topics Energy Intellectual Property

3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗

November 30, 2025

There are plenty of potential winners outside the world of AI.

Via The Motley Fool

Topics Artificial Intelligence

Why Novo Nordisk Stock Just Hit a 4-Year Low ↗

November 29, 2025

Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company.

Via The Motley Fool

Friday's session: most active stock in the S&P500 index ↗

November 28, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

8 Dividend Stocks Every Investor Should Consider ↗

November 28, 2025

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

Via The Motley Fool

Is Pfizer Stock Underperforming the Dow?

November 28, 2025

While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.

Via Barchart.com

Topics Intellectual Property Stocks

Roivant (ROIV) Q2 2026 Earnings Call Transcript ↗

November 27, 2025

Roivant (ROIV) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years ↗

November 27, 2025

These top dividend stocks could intrigue a wide range of investors.

Via The Motley Fool

Topics Intellectual Property

JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗

November 26, 2025

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Via Stocktwits

Topics Economy Government

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings ↗

November 26, 2025

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Via Benzinga

Merck & Co. Stock: Is MRK Outperforming the Healthcare Sector?

November 26, 2025

Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects.

Via Barchart.com

Topics ETFs

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.